Published in Eur Arch Psychiatry Clin Neurosci on August 01, 2001
Deconstructing Psychosis conference February 2006: the validity of schizophrenia and alternative approaches to the classification of psychosis. Schizophr Bull (2007) 1.05
Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis? Soc Psychiatry Psychiatr Epidemiol (2007) 0.86
Categorical vs dimensional classifications of psychotic disorders. Compr Psychiatry (2012) 0.79
Predictors of response in a sample of treatment-resistant psychotic patients on clozapine. Eur Arch Psychiatry Clin Neurosci (2004) 0.78
Influence of postpartum onset on the course of mood disorders. BMC Psychiatry (2006) 0.75
A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches. Ann Gen Psychiatry (2015) 0.75
Can Psychological, Social and Demographical Factors Predict Clinical Characteristics Symptomatology of Bipolar Affective Disorder and Schizophrenia? Psychiatr Q (2016) 0.75
Harnessing clinical psychiatric data with an electronic assessment tool (OPCRIT+): the utility of symptom dimensions. PLoS One (2013) 0.75
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry (2007) 6.72
Tensile forces govern germ-layer organization in zebrafish. Nat Cell Biol (2008) 5.31
Unfolding pathways of individual bacteriorhodopsins. Science (2000) 5.08
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2008) 3.85
Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry (2009) 3.64
Mind reading: neural mechanisms of theory of mind and self-perspective. Neuroimage (2001) 3.03
Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care (1997) 2.63
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry (2008) 2.50
Structural biology. Proton-powered turbine of a plant motor. Nature (2000) 2.40
Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. Clin Pharmacol Ther (2013) 2.38
Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care (1997) 2.32
Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29
Observing single biomolecules at work with the atomic force microscope. Nat Struct Biol (2000) 2.28
The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry (2010) 2.23
The Hamilton scales and the Hopkins Symptom Checklist (SCL-90). A cross-national validity study in patients with panic disorders. Br J Psychiatry (1992) 2.16
Net costs of dementia by disease stage. Acta Psychiatr Scand (2011) 2.11
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry (2010) 2.00
Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet (1999) 1.98
Tolerance and withdrawal with zolpidem. Lancet (1993) 1.97
Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res (1998) 1.95
Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry (2008) 1.92
Subcortical correlates of craving in recently abstinent alcoholic patients. Am J Psychiatry (2001) 1.84
Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants. Mol Psychiatry (2012) 1.84
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J (2005) 1.83
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology (2012) 1.78
Risk factors for incident mild cognitive impairment--results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe). Acta Psychiatr Scand (2009) 1.76
Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement. Mol Psychiatry (2008) 1.72
Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry (1997) 1.66
Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry (2011) 1.65
Detection of Coxiella burnetii in cow's milk using the polymerase chain reaction (PCR). Zentralbl Veterinarmed B (1994) 1.65
A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann Neurol (2000) 1.61
Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study. J Clin Psychiatry (2000) 1.60
Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry (2004) 1.60
Bacterial Na(+)-ATP synthase has an undecameric rotor. EMBO Rep (2001) 1.59
Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry (2006) 1.59
Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Mol Psychiatry (1999) 1.59
Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task. Mol Psychiatry (2010) 1.57
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Prevalence and recognition of anxiety syndromes in five European primary care settings. A report from the WHO study on Psychological Problems in General Health Care. Br J Psychiatry Suppl (1998) 1.57
Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74 years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med (2012) 1.56
Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder. Arch Gen Psychiatry (2001) 1.56
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55
Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry (1996) 1.55
Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am J Psychiatry (1999) 1.53
A congenital teratoma with a cleft palate: report of a case. Br J Oral Maxillofac Surg (2005) 1.50
Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing. Clin Pharmacol Ther (2013) 1.49
Essential functions of the human self model are implemented in the prefrontal cortex. Conscious Cogn (1999) 1.48
Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med (2011) 1.45
A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiatry (2000) 1.45
Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry (2011) 1.44
Risk factors for new depressive episodes in primary health care: an international prospective 12-month follow-up study. Psychol Med (2002) 1.44
Two-year maintenance treatment with citalopram, 20 mg, in unipolar subjects with high recurrence rate. J Clin Psychiatry (1999) 1.43
The plant sterol brassicasterol as additional CSF biomarker in Alzheimer's disease. Acta Psychiatr Scand (2011) 1.43
Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorder. Mol Psychiatry (2011) 1.43
A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet (2001) 1.42
Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry (2010) 1.41
Trajectories of change in depression severity during treatment with antidepressants. Psychol Med (2009) 1.40
Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry (2011) 1.40
[Chondrosarcoma of the larynx. Experience gained in Freiburg since 1999]. HNO (2011) 1.40
[Infant mortality, age of the mothers and number of children]. Arch Gynakol (1965) 1.39
[Encephalopathy following poisoning with an anticholinergic agent]. Dtsch Med Wochenschr (1994) 1.39
Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry (2006) 1.38
[Psychiatric diseases and their treatment in general practice in Germany. Results of a World Health Organization (WHO) study]. Nervenarzt (1996) 1.38
An economic model of the long-term health care burden of Type II diabetes. Diabetologia (2001) 1.37
Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke. Neurology (2004) 1.36
Tapping-mode atomic force microscopy produces faithful high-resolution images of protein surfaces. Biophys J (1999) 1.35
Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis". J Psychiatr Res (2000) 1.34
Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry (2005) 1.34
High resolution AFM topographs of the Escherichia coli water channel aquaporin Z. EMBO J (1999) 1.34
Cloning, genomic organization, alternative transcripts and mutational analysis of the gene responsible for autosomal recessive universal congenital alopecia. Hum Mol Genet (1998) 1.34
Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging. Gut (1986) 1.32
Surface tongue-and-groove contours on lens MIP facilitate cell-to-cell adherence. J Mol Biol (2000) 1.32
Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med (2007) 1.31
Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry (1998) 1.29
Familial occurrence of primary premature ejaculation. Psychiatr Genet (1998) 1.29
Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression. Psychiatry Res (1999) 1.29
The neural basis of video gaming. Transl Psychiatry (2011) 1.28
Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Mol Psychiatry (2008) 1.28
Electron microscopic studies on the attachment of Mycoplasma pneumoniae to guinea pig erythrocytes. Infect Immun (1979) 1.27
Q fever in Europe: current aspects of aetiology, epidemiology, human infection, diagnosis and therapy. Infection (1987) 1.27
Effects of a CACNA1C genotype on attention networks in healthy individuals. Psychol Med (2010) 1.27